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Collagen Defect Found In A Severe Form of Epidermolysis Bullosa 
A variety of evidence has suggested that the hereditary forms of 
epidermolysis bullosa (EB) are caused by defective anchoring fibrils. 
Researchers have generally found that these fibrils, which are lo-
cated between the dermis and epidermis and help to hold the two 
skin layers together, are absent, reduced in number, or otherwise 
abnormal in the skin of patients with hereditary EB. 
In this issue, Leena Bruckner-Tuderman, Yoshihiko Mitsuhashi, 
Urs Schnyder, and Peter Bruckner of the University Hospital and 
the Swiss Federal Institute of Technology in Zurich report that the 
anchoring fibrils are missing in at least some patients with heredi-
tary EB because the patients' skin lacks type VII collagen, the prin-
cipal protein component of the fibrils. Bruckner-Tuderman stresses, 
however, that this finding may apply only to patients with the 
mutilating form of severe generalized recessive dystrophic EB 
(SGRDEB). 
The Zurich workers examined skin samples from four patients 
with mutilating SGRDEB and from normal controls. They found 
that type VII collagen was readily detectable in the control skin, but 
not in the patients' samples. "We have shown that we can't find 
type VII collagen in the skin of these patients by several methods. 
The absence of the anchoring fibrils is the result of the absence of 
type VII collagen," Bruckner-Tuderman concludes. 
The researchers have not yet identified the defect in SGRDEB 
skin that causes the type VII collagen deficiency. The problem 
could be at any stage in the synthesis or assembly of the collagen 
molecule, or the protein might be made, but rapidly broken down 
by collagenase enzymes. 
In the past, there have been discrepancies in researchers' findings 
concerning the anchoring fibrils and type VII collagen content of 
skin from patients with recessive dystrophic EB. In some cases no 
anchoring fibrils or type VII collagen have been found, whereas in 
others the materials have been present. Recessive dystrophic Ell is 
apparently a heterogeneous disease with different manifestations 
that may be caused by diverse genetic defects. For this reason, the 
Zurich workers note that the different subgroups of patients may 
not be comparable. However, the absence of type VII collagen may 
be characteristic of the subgroup with the most severe form of 
dystrophic Ell, and may be useful for doing prenatal diagnosis of the 
condition in families known to be affected by the disease. 
Keratinocytes in Culture Show Lipid Changes Similar to Those in Skin 
As keratinocytes move from the living layer of the epidermis of the 
skin into the stratum corneum, the composition of the lipids they 
make changes dramatically. Until recently, those changes could not 
be studied readily. " It 's been difficult to look at lipid metabolism 
because the cultures weren't adequate," says Kathi Madison of the 
University of Iowa College of Medicine in Iowa City. 
In this issue, however, Madison and her Iowa colleagues Donald 
Swartzendruber, Philip Wertz and Donald Downing report that a 
new cu lture system that they have developed gives much improved 
results when it comes to studying lipid metabolism during keratino-
cyte differentiation. "We showed that the composition changes in 
lipids that accompany differentiation were reproduced in these cul-
tures," Madison says. 
In the culture system devised by the Iowa workers, keratinocytes 
are grown over a layer of mouse dermis in such a way that the 
keratinocytes are at the interface between the liquid cu lture medium 
and the air (see Madison et al,J Invest Derlllatol90:1 10, 1988). When 
cultured this way, the cells undergo morphological changes much 
like those seen in the keratinocytes of the skin as they move up from 
the bottom layer of the epidermis into the stratum corneum. 
In the skin, the living layer of the epidermis is rich in the phos-
pholipids and glucosyl ceramides. In contrast, the stratum corneum 
contains little of these lipids, but has, instead, a high proportion of 
the linoleic acid-containing ceramides and free fatty acids. As the 
culture~ cells become cornified, they shift their pattern of lipid 
syntheSIS, the Iowa workers now find, so that it becomes more like 
that seen in the stratum corneum. Keratinocytes grown the old way, 
on plastic and submerged in the culture fluid, do not show this shift 
but continue to produce a lipid pattern more like that of the less-dif-
ferentiated cells of the living epidermal layer. 
The way is now open, Madison says, to study the pathways of 
lipid metabolism and their control in keratinocytes differentiating 
in culture. This will help in understanding not only the normal 
formation of the lipid layer of the stratum corneum, which is the 
body's main barrier to water loss, but also the abnormalities in lipid 
m~tabolis~ that may occur in disease states such as essential fatty 
aCId defiCIency and recessive X-linked ichthyosis. 
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Gamma-Interferon Inhibits Wound Healing and Inflammation in Mice 
The lymphokines, the molecules by which the cells of the immune 
system communicate with one another, have also been implicated as 
regulators of inflammation and wound healing, at least in in vitro 
systems. In this issue. Richard Granstein, Mary Rose Deak, Steven 
Jacques, Randall Margolis, Thomas Flote, Diana Whitaker, Freder-
ick Long, and Edward Amento of Massachusetts General Hospital 
and Harvard Medical School in Boston now report that the lym-
phokine gamma-interferon inhibits wound healing when adminis-
tered systemically to mice. Its systemic effects were not completely 
as predicted by the in vitro results, however. 
To study the in vivo effects of gamma-interferon on wound heal-
ing, Granstein and his colleagues used a laser to wound the skin of 
anesthetized mice. The researchers found that the time required for 
the damaged skin to heal was about 25% longer in animals that were 
treated with gamma-interferon, which was administered either sub-
cutaneously or intraperitoneally. The wounds of the treated animals 
contained less coll agen than those of controls. "You can reduce 
collagen synthesis at a distant si te with gamma-interferon." Gran-
stein says. 
This result is consistent with previous findings in which re-
searchers. including members of the Harvard group, had shown that 
the Iymphokine inhibits collagen synthesis by cells growing in cul-
ture. The reduced synthesis in vitro. and possibly in vivo as well. is 
the result of decreased expression of the collagen genes. 
The Harvard workers found, however. that gamma-interferon 
administration reduced the inflammatory changes in the healing 
wounds. It also inhibited the responses to known inflammatory 
agents, including interleukin 1. "The inflammation results were a 
real surprise," Granstein remarks. "Based on in vitro studies. one 
would have predicted that gamma-interferon would have increased 
inflammation." For example, the in vitro work indicated that the 
lymphokine attracts white blood cells. yet the damaged skin of the 
treated animals contained fewer inflammatory cells than that of the 
control animals. The mechanism of the anti-inflammatory action of 
gamma-interferon in vivo is not yet known. 
The information being gleaned in these studies may have clinical 
significance. Granstein says. It may be possible to use gamma-inter-
feron to prevent the abnormal collagen accumulation that occurs in 
keloid scars or in diseases such as scleroderma. The agent may also 
have potential as an anti-inflammatory agent. 
